ARGX 213
Alternative Names: ARGX-213Latest Information Update: 02 Aug 2024
At a glance
- Originator argenx
- Class Antibodies
- Mechanism of Action Neonatal Fc receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
- Available For Licensing Yes
Highest Development Phases
- Preclinical Immunological disorders